PCLO — Pharmacielo Cashflow Statement
0.000.00%
Last trade - 00:00- CA$8.46m
- CA$30.64m
- CA$3.97m
- 14
- 35
- 18
- 10
Annual cashflow statement for Pharmacielo, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | C2022 December 31st | 2023 December 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 15 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -43.8 | -26.6 | -14.5 | -16.3 | -11.4 |
| Depreciation | |||||
| Non-Cash Items | 16.3 | 12.9 | 4.85 | 7.52 | 6.55 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 3.31 | -7.58 | -1.79 | 2.22 | 1.07 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -22.6 | -20.1 | -9.88 | -5.15 | -2.11 |
| Capital Expenditures | -5.43 | -1.14 | -0.522 | -0.015 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -0.138 | -0.519 | -0.036 | 0.407 | 0.041 |
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -5.57 | -1.66 | -0.558 | 0.392 | 0.041 |
| Financing Cash Flow Items | -1.88 | -1.28 | 0.04 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 23.3 | 18.2 | 5.3 | 4.63 | 2.06 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -4.81 | -3.52 | -5.17 | -0.111 | -0.008 |